Tongle Zhi

1.3k total citations
28 papers, 957 citations indexed

About

Tongle Zhi is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Tongle Zhi has authored 28 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Tongle Zhi's work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (9 papers). Tongle Zhi is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (9 papers). Tongle Zhi collaborates with scholars based in China. Tongle Zhi's co-authors include Tianfu Yu, Yingyi Wang, Junxia Zhang, Er Nie, Kuan Jiang, Yongping You, Ning Liu, Weining Wu, Xiupeng Xu and Fengqi Zhou and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Tongle Zhi

28 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tongle Zhi China 20 767 602 113 87 73 28 957
Er Nie China 18 694 0.9× 578 1.0× 118 1.0× 69 0.8× 53 0.7× 22 852
Lynette M. Moore United States 10 648 0.8× 481 0.8× 146 1.3× 175 2.0× 47 0.6× 12 899
Hai Yu China 16 565 0.7× 446 0.7× 67 0.6× 162 1.9× 105 1.4× 31 792
Kara M. Foshay United States 12 446 0.6× 257 0.4× 104 0.9× 92 1.1× 33 0.5× 15 652
Bakhos A. Tannous United States 6 825 1.1× 777 1.3× 72 0.6× 55 0.6× 26 0.4× 6 991
Ci-Xiang Zhou China 13 620 0.8× 583 1.0× 130 1.2× 111 1.3× 83 1.1× 18 866
Juan M. Funes United Kingdom 10 447 0.6× 196 0.3× 87 0.8× 198 2.3× 109 1.5× 15 686
Qin Niu China 13 381 0.5× 265 0.4× 71 0.6× 145 1.7× 43 0.6× 17 565
Ae Kyung Park South Korea 15 334 0.4× 211 0.4× 119 1.1× 101 1.2× 114 1.6× 28 647
Jinghai Wan China 15 316 0.4× 195 0.3× 133 1.2× 155 1.8× 142 1.9× 48 628

Countries citing papers authored by Tongle Zhi

Since Specialization
Citations

This map shows the geographic impact of Tongle Zhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongle Zhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongle Zhi more than expected).

Fields of papers citing papers by Tongle Zhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tongle Zhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongle Zhi. The network helps show where Tongle Zhi may publish in the future.

Co-authorship network of co-authors of Tongle Zhi

This figure shows the co-authorship network connecting the top 25 collaborators of Tongle Zhi. A scholar is included among the top collaborators of Tongle Zhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tongle Zhi. Tongle Zhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Liang, et al.. (2023). CircAFF2 Promotes Neuronal Cell Injury in Intracerebral Hemorrhage by Regulating the miR-488/CLSTN3 Axis. Neuroscience. 535. 75–87. 6 indexed citations
2.
Zhang, Yang, et al.. (2023). Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma. BMC Cancer. 23(1). 846–846. 1 indexed citations
3.
4.
Xu, Xiupeng, Tongle Zhi, Lingyang Hua, Kuan Jiang, & Chen Chen. (2022). IRAK4 exacerbates traumatic brain injury via activation of TAK1 signaling pathway. Experimental Neurology. 351. 114007–114007. 6 indexed citations
5.
Liu, Yinlong, Kuan Jiang, Tongle Zhi, & Xiupeng Xu. (2021). miR-720 is a key regulator of glioma migration and invasion by controlling TARSL2 expression. Human Cell. 34(5). 1504–1516. 6 indexed citations
6.
Wang, Jun, Dekang Nie, Xu Song, et al.. (2019). FRK suppresses human glioma growth by inhibiting ITGB1/FAK signaling. Biochemical and Biophysical Research Communications. 517(4). 588–595. 11 indexed citations
7.
Zhou, Fengqi, Ran Xu, Junxia Zhang, et al.. (2019). MicroRNA-206 attenuates glioma cell proliferation, migration, and invasion by blocking the WNT/β-catenin pathway via direct targeting of Frizzled 7 mRNA.. PubMed. 11(7). 4584–4601. 17 indexed citations
8.
Nie, Er, Xin Jin, Weining Wu, et al.. (2018). Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma. Oncogene. 38(15). 2706–2721. 37 indexed citations
9.
Xu, Xiupeng, Zhongyuan Bao, Yinlong Liu, et al.. (2018). PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion. Journal of Experimental & Clinical Cancer Research. 37(1). 158–158. 29 indexed citations
10.
Xu, Xiupeng, Tongle Zhi, Honglu Chao, et al.. (2018). ERK1/2/mTOR/Stat3 pathway-mediated autophagy alleviates traumatic brain injury-induced acute lung injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(5). 1663–1674. 38 indexed citations
11.
Yu, Tianfu, Xiefeng Wang, Tongle Zhi, et al.. (2018). Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype. Cancer Letters. 433. 210–220. 82 indexed citations
12.
Jin, Xin, Er Nie, Xu Zhou, et al.. (2017). Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway. Cellular Physiology and Biochemistry. 44(4). 1616–1628. 26 indexed citations
13.
Wang, Dong, Tongle Zhi, Xiupeng Xu, et al.. (2017). MicroRNA-936 induces cell cycle arrest and inhibits glioma cell proliferation by targeting CKS1.. PubMed. 7(11). 2131–2143. 21 indexed citations
14.
Wu, Weining, Xu Zhou, Tianfu Yu, et al.. (2017). The malignancy of miR-18a in human glioblastoma via directly targeting CBX7.. PubMed. 7(1). 64–76. 22 indexed citations
15.
Wang, Yingyi, Tianfu Yu, Er Nie, et al.. (2017). Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma. Neuro-Oncology. 19(9). 1195–1205. 109 indexed citations
16.
Zhou, Xu, Weining Wu, Ailiang Zeng, et al.. (2017). MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53. Oncotarget. 8(41). 71080–71094. 45 indexed citations
17.
Nie, Er, Xin Jin, Weining Wu, et al.. (2016). BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53. Scientific Reports. 6(1). 39743–39743. 32 indexed citations
18.
Zhi, Tongle, Er Nie, Xuebin Xu, et al.. (2014). Bex2 Controls Proliferation of Human Glioblastoma Cells Through NF-κB Signaling Pathway. Journal of Molecular Neuroscience. 53(2). 262–270. 21 indexed citations
19.
Zhou, Xiuping, Xuebin Xu, Tongle Zhi, et al.. (2012). Bex2 regulates cell proliferation and apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway. Biochemical and Biophysical Research Communications. 427(3). 574–580. 24 indexed citations
20.
Zhou, Xiuping, Xuebin Xu, Jinxia Hu, et al.. (2012). Bex2 is Critical for Migration and Invasion in Malignant Glioma Cells. Journal of Molecular Neuroscience. 50(1). 78–87. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026